|
gptkbp:instance_of
|
gptkb:Planned_Parenthood
|
|
gptkbp:availability
|
prescription only
|
|
gptkbp:brand
|
gptkb:Ortho_Tri-Cyclen
|
|
gptkbp:class
|
combination oral contraceptive
|
|
gptkbp:clinical_trial
|
conducted for safety and efficacy
|
|
gptkbp:contraindication
|
liver disease
certain cancers
history of blood clots
smoking over age 35
|
|
gptkbp:counseling_services
|
monitor for side effects
missed dose instructions
take at the same time daily
not protect against STIs
|
|
gptkbp:cycle_length
|
28 days
|
|
gptkbp:dosage_form
|
combination hormonal contraceptive
|
|
gptkbp:effective_date
|
gptkb:1996
|
|
gptkbp:fda_category
|
Category X
|
|
gptkbp:first_introduced
|
gptkb:1996
|
|
gptkbp:form
|
oral tablet
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Ortho Tri-Cyclen
|
|
gptkbp:ingredients
|
gptkb:norgestimate
gptkb:ethinyl_estradiol
|
|
gptkbp:interacts_with
|
gptkb:St._John's_Wort
antibiotics
anticonvulsants
HIV medications
|
|
gptkbp:is_effective_against
|
over 99% with perfect use
91% with typical use
|
|
gptkbp:manufacturer
|
gptkb:Johnson_&_Johnson
|
|
gptkbp:marketed_as
|
gptkb:Europe
gptkb:Ortho_Pharmaceuticals
gptkb:Asia
gptkb:Australia
gptkb:North_America
|
|
gptkbp:mechanism_of_action
|
prevents ovulation
thickens cervical mucus
thins uterine lining
|
|
gptkbp:number_of_active_pills
|
gptkb:21
|
|
gptkbp:number_of_inactive_pills
|
gptkb:7
|
|
gptkbp:patient_population
|
women of reproductive age
|
|
gptkbp:previous_name
|
norgestimate and ethinyl estradiol
|
|
gptkbp:related_products
|
gptkb:Nuva_Ring
gptkb:Ortho_Evra
gptkb:Ortho_Tri-Cyclen_Lo
|
|
gptkbp:requires
|
gptkb:true
|
|
gptkbp:route_of_administration
|
oral
|
|
gptkbp:side_effect
|
headache
nausea
weight gain
breast tenderness
mood changes
|
|
gptkbp:used_for
|
contraception
|
|
gptkbp:withdrawal_method
|
not recommended as sole method
|
|
gptkbp:bfsParent
|
gptkb:Johnson_&_Johnson
|
|
gptkbp:bfsLayer
|
4
|